Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

Acasti Pharma logo

About Acasti Pharma Stock (NASDAQ:ACST)

Advanced Chart

Key Stats

Today's Range
$3.03
$3.14
50-Day Range
$2.56
$3.60
52-Week Range
$1.98
$3.60
Volume
12,261 shs
Average Volume
22,722 shs
Market Capitalization
$29.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Buy

Company Overview

Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

ACST Stock News Headlines

Why Volatility Keeps Coming Back — And How I Trade It
Volatility isn’t the enemy — it’s the opportunity. While most traders panic during market swings, Jeff Clark uses a three-step method to target quick wins from VIX spikes and sudden price moves. It works in any market direction… and he’s showing how it works in a free video, available now.
Craig-Hallum Sticks to Their Buy Rating for Acasti Pharma (ACST)
See More Headlines

ACST Stock Analysis - Frequently Asked Questions

Acasti Pharma Inc. (NASDAQ:ACST) issued its quarterly earnings data on Friday, June, 21st. The biopharmaceutical company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.48) by $0.30.

Shares of Acasti Pharma reverse split before market open on Monday, July 10th 2023.The 1-6 reverse split was announced on Monday, July 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acasti Pharma investors own include NVIDIA (NVDA), Meta Platforms (META), GE Aerospace (GE), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
6/21/2024
Today
7/10/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACST
CIK
1444192
Employees
32
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$8.00
Potential Upside/Downside
+221.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.85 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$6.57 per share
Price / Book
0.47

Miscellaneous

Free Float
8,770,000
Market Cap
$29.23 million
Optionable
Not Optionable
Beta
1.52
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:ACST) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners